Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.

Bill Information - History

House Bill 2211; Regular Session 2017-2018

Text

[History]

[Votes]

Sponsors:

WARD, CORBIN, BOBACK, MILLARD, ORTITAY, ROTHMAN, JAMES, PICKETT, McGINNIS, RAPP, READSHAW, OBERLANDER, PASHINSKI, FLYNN, B. MILLER, MENTZER, TOEPEL, IRVIN, SCHLEGEL CULVER, CRUZ, HEFFLEY, J. McNEILL, GROVE, HILL-EVANS, SAYLOR, COX, WATSON, JOZWIAK, FARRY, PHILLIPS-HILL, FEE, LONGIETTI, CHARLTON, BARRAR, GILLEN, PEIFER, KAUFFMAN, KLUNK, MATZIE, KORTZ, HELM, MEHAFFIE, B. O'NEILL, STAATS, RAVENSTAHL, C. QUINN and BERNSTINE

Printer's No.(PN):

3665*, 3578

Short Title:

An Act providing for consumer prescription drug pricing disclosure.

Actions:

	PN 3578	Referred to HEALTH, May 29, 2018
	PN 3665	Reported as amended, June 12, 2018
		First consideration, June 12, 2018
		Re-committed to RULES, June 12, 2018
		Re-reported as committed, June 21, 2018
		Second consideration, June 21, 2018
		Re-committed to APPROPRIATIONS, June 21, 2018
		Re-reported as committed, June 22, 2018
		Third consideration and final passage, June 22, 2018 (194-0)
		(Remarks see House Journal Page 968-969), June 22, 2018
		In the Senate
		Referred to BANKING AND INSURANCE, June 22, 2018
		Reported as committed, Sept. 25, 2018
		First consideration, Sept. 25, 2018
		Second consideration, Sept. 26, 2018

* denotes current Printer's Number

How to Read a Bill About PDF Documents